Literature DB >> 19657941

An axon regeneration signature in a Charcot-Marie-Tooth disease type 2 patient.

Francesca Cavalcanti1, Thomas Kidd, Alessandra Patitucci, Paola Valentino, Francesco Bono, Rita Nisticò, Aldo Quattrone.   

Abstract

Charcot-Marie-Tooth disease (CMT) is one of the most common inherited peripheral neuropathies. The underlying mutations in demyelinating forms tend to affect genes expressed in Schwann cells (CMT types 1, 3, and 4), while axonal forms of the disease usually have their origins in genes expressed in the affected neurons (CMT type 2). Repeated rounds of nerve degeneration and regeneration characterize CMT2, but evidence for regeneration has not been demonstrated at a molecular level. Subtractive hybridization was performed on sural nerve biopsies from a patient presenting an axonal form of CMT and an unaffected sibling, which revealed an overexpression of genes associated with the regeneration of axons, including PMP22, SPARC/osteonectin, CD9, CD44, EEF1A1, and gamma-actin. These results suggest that axonal degeneration elicits a regeneration transcriptional response in the surrounding Schwann cells. This response contrasts with other neurodegenerative diseases, in which programmed cell death or an inappropriate immune response are activated. Additionally, Lamin A/C, which is mutated in CMT2B1, was overexpressed in the patient, suggesting that CMT-causing genes may interact in a regulatory network.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657941      PMCID: PMC2716698          DOI: 10.1080/01677060802447585

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  16 in total

1.  Regulation of the cell adhesion molecule CD44 after nerve transection and direct trauma to the mouse brain.

Authors:  L L Jones; Z Liu; J Shen; A Werner; G W Kreutzberg; G Raivich
Journal:  J Comp Neurol       Date:  2000-10-23       Impact factor: 3.215

2.  Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation.

Authors:  Suzana Atanasoski; Danielle Boller; Lukas De Ventura; Heidi Koegel; Matthias Boentert; Peter Young; Sabine Werner; Ueli Suter
Journal:  Glia       Date:  2006-01-15       Impact factor: 7.452

3.  Gene expression profiling reveals that peripheral nerve regeneration is a consequence of both novel injury-dependent and reactivated developmental processes.

Authors:  Frank Bosse; Kerstin Hasenpusch-Theil; Patrick Küry; Hans Werner Müller
Journal:  J Neurochem       Date:  2006-03       Impact factor: 5.372

Review 4.  Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease.

Authors:  D Pareyson; V Scaioli; M Laurà
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

5.  Schwann cell CD9 expression is regulated by axons.

Authors:  S A Banerjee; P H Patterson
Journal:  Mol Cell Neurosci       Date:  1995-10       Impact factor: 4.314

6.  Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation.

Authors:  Guya Giambonini-Brugnoli; Johanna Buchstaller; Lukas Sommer; Ueli Suter; Ned Mantei
Journal:  Neurobiol Dis       Date:  2005-04       Impact factor: 5.996

7.  Up-regulation of a chondroitin sulphate epitope during regeneration of mouse sciatic nerve: evidence that the immunoreactive molecules are related to the chondroitin sulphate proteoglycans decorin and versican.

Authors:  K H Braunewell; R Martini; R LeBaron; H Kresse; A Faissner; B Schmitz; M Schachner
Journal:  Eur J Neurosci       Date:  1995-04-01       Impact factor: 3.386

8.  Differentially expressed genes after peripheral nerve injury.

Authors:  C Gillen; M Gleichmann; P Spreyer; H W Müller
Journal:  J Neurosci Res       Date:  1995-10-01       Impact factor: 4.164

9.  Analysis of gene expression during neurite outgrowth and regeneration.

Authors:  Moriah L Szpara; Karen Vranizan; Yu Chuan Tai; Corey S Goodman; Terence P Speed; John Ngai
Journal:  BMC Neurosci       Date:  2007-11-23       Impact factor: 3.288

10.  Comparing gene discovery from Affymetrix GeneChip microarrays and Clontech PCR-select cDNA subtraction: a case study.

Authors:  Wuxiong Cao; Charles Epstein; Hong Liu; Craig DeLoughery; Nanxiang Ge; Jieyi Lin; Rong Diao; Hui Cao; Fan Long; Xin Zhang; Yangde Chen; Paul S Wright; Steve Busch; Michelle Wenck; Karen Wong; Alan G Saltzman; Zhihua Tang; Li Liu; Asher Zilberstein
Journal:  BMC Genomics       Date:  2004-04-27       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.